• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 17, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Vestigo Aerospace raises $375K in seed funding to spur deorbit systems

Bioengineer by Bioengineer
September 12, 2022
in Science News
Reading Time: 3 mins read
0
Vestigo Aerospace
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

LOS ANGELES and WEST LAFAYETTE, Ind. — Vestigo Aerospace, a space technology company focused on deorbit systems, has closed a seed funding round with an investment of $375,000 from Manhattan West, a Los Angeles-based strategic investment firm. NASA will provide a 1:1 match of Manhattan West’s investment through a Small Business Innovative Research Phase II-Extended (SBIR Phase II-E) contract.

Vestigo Aerospace

Credit: Photo provided by David Spencer

LOS ANGELES and WEST LAFAYETTE, Ind. — Vestigo Aerospace, a space technology company focused on deorbit systems, has closed a seed funding round with an investment of $375,000 from Manhattan West, a Los Angeles-based strategic investment firm. NASA will provide a 1:1 match of Manhattan West’s investment through a Small Business Innovative Research Phase II-Extended (SBIR Phase II-E) contract.

The seed funding and the matching NASA SBIR Phase II-E award will enable Vestigo Aerospace to establish the commercial manufacturing process for Vestigo’s product line of dragsails currently in development. The dragsails are designed to enable the timely deorbit of space vehicles, including CubeSats, small satellites and launch vehicle upper stages. Initial sales are anticipated for 2023.

Vestigo’s dragsails offer standardized mechanical and electrical interfaces to the host vehicle, allowing straightforward integration. The dragsails can be deployed on command or via a backup timer, providing reliable deorbit capability even if the host vehicle is inoperative.

“The Spinnaker product line of dragsails addresses the growing need for reliable end-of-mission deorbit capability in order to maintain the sustainability of low-Earth orbit,” said David Spencer, founder and CEO of Vestigo Aerospace. “Bolt-on dragsails represent an ‘ounce of prevention’ approach to the orbital debris problem that, if left unchecked, could halt the growth of the orbital economy.”

“At Manhattan West, we are committed to being active investors in emerging spaces and disruptive sectors, and identifying long-term secular shifts developing in the markets,” said Lorenzo Esparza, founding principal and CEO at Manhattan West. “We’re thrilled that our strategic investment in Vestigo will support the company’s development as it establishes its name as a leading player in deorbit systems and the space industry.”

The Spinnaker dragsails are sized to enable the host vehicle to meet regulatory guidelines for deorbit duration. The U.S. Federal Communications Commission mandates deorbit from low-Earth orbit within 25 years of end-of-mission. The FCC offers streamlined licensing, with cost savings in application fees of over $440,000, for commercial small satellites that can deorbit within six years of launch.

Before the seed round, Vestigo Aerospace funded dragsail technology development through NASA SBIR Phase I and Phase II contracts, and matching funds from Indiana-based Elevate Ventures. For more information on the evolution of Vestigo and its commercial dragsail solutions, visit vestigoaerospace.com.

Spencer is a Purdue University adjunct associate professor from the School of Aeronautics and Astronautics and director of the Space Flight Projects Laboratory. Vestigo Aerospace licensed the dragsail technology through the Purdue Research Foundation of Office Technology Commercialization. The company was a client of the Purdue Foundry, an entrepreneurship and commercialization hub whose professionals help Purdue innovators create startups.

About Vestigo Aerospace

Established in 2019, Vestigo Aerospace has quickly become an industry leader in dragsail technology. Vestigo is committed to preserving the space environment and high-utility orbits through providing end-of-mission deorbit capability for space vehicles. For more information, visit vestigoaerospace.com.

About Manhattan West

Manhattan West is a global strategic investment firm based in Los Angeles that provides proprietary alternative investments across multiple asset classes including Private Equity, Venture Capital, Real Estate, Private Debt and traditional equity and fixed income portfolios, as well as financial services including business management, tax and planning. To learn more about us, visit manhattanwest.com.

About Purdue Research Foundation

Purdue Research Foundation supports Purdue University’s land-grant mission by helping the university improve the world through its technologies and graduates. Established in 1930, PRF is a private, nonprofit foundation. The foundation helps patent and commercialize Purdue technologies; builds places to encourage innovation, invention, investment, commercialization and entrepreneurship; and makes equity available to students to finance their Purdue education. For more information on licensing a Purdue innovation, contact the Office of Technology Commercialization at [email protected]. For more information about involvement and investment opportunities in startups based on a Purdue innovation, contact the Purdue Foundry at [email protected].

Contacts: Vestigo Aerospace: [email protected], 818-928-9964

Manhattan West: StreetCred PR, [email protected]; Will Ruben, [email protected], 847-208-8289; Meaghan McNichol, [email protected], 412-720-3777

Purdue Research Foundation: Steve Martin, [email protected]



Share12Tweet8Share2ShareShareShare2

Related Posts

Gaza’s Temporary “Medical Points” Provide Care to 117 Patients Daily with Minimal Staff

September 17, 2025

Evaluating Sickle Cell Gene Therapy Costs for Medicaid

September 17, 2025

3D Jaw Analysis Uncovers Omnivorous Diet of Early Bears

September 17, 2025

Neonatal Liver Immunity Altered by Phlebotomy Anemia

September 17, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Gaza’s Temporary “Medical Points” Provide Care to 117 Patients Daily with Minimal Staff

Evaluating Sickle Cell Gene Therapy Costs for Medicaid

3D Jaw Analysis Uncovers Omnivorous Diet of Early Bears

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.